Compare TAYD & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAYD | LNSR |
|---|---|---|
| Founded | 1955 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.1M | 142.0M |
| IPO Year | N/A | N/A |
| Metric | TAYD | LNSR |
|---|---|---|
| Price | $48.81 | $11.21 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 4.7K | ★ 70.7K |
| Earning Date | 01-02-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.72 | N/A |
| Revenue | $44,593,219.00 | ★ $59,141,000.00 |
| Revenue This Year | $10.81 | $19.55 |
| Revenue Next Year | $8.37 | $35.89 |
| P/E Ratio | $17.48 | ★ N/A |
| Revenue Growth | N/A | ★ 21.02 |
| 52 Week Low | $29.50 | $7.13 |
| 52 Week High | $53.73 | $17.31 |
| Indicator | TAYD | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 51.56 | 56.52 |
| Support Level | $47.74 | $10.14 |
| Resistance Level | $50.56 | $10.48 |
| Average True Range (ATR) | 1.33 | 0.46 |
| MACD | -0.06 | 0.20 |
| Stochastic Oscillator | 58.94 | 82.46 |
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.